EQL Pharma AB's (publ) Chief Financial Officer (CFO) Jennie Sterning has chosen to leave her position. Jennie has been active in EQL Pharma since 2007 and CFO since 2016. Jennie will remain as CFO until mid-July. During her time at EQL Pharma, Jennie has built and developed EQL's finance function. She has also implemented financial management and the GDPR regulations within EQL. Recently, she has focused on the conversion to IFRS and the preparations for EQLs move to Nasdaq Stockholm's main exchange. Emanuel Eriksson will take over as acting CFO during the period from Jennie Sterning's last day until a new long-term CFO is in place.